COVID-19(9) pharmacokinetics(7) develop(6) less(6) Human(6) Formulation(6) SARS-CoV-2(4) Pharmacokinetic/pharmacodynamic (PK/PD) modeling(3) repurposing(3) operation(3) doses(3) IC50(3) measure(3) were used(3) Inhaled(3) while(3) Prevent(3) social distancing(3) cellular(3) host cell(3) majority(3) Biopharmaceutics(3) Physiologically based pharmacokinetic modeling(3) organized(3) Disease progression(3) lung(3) platform(3) therapeutic potential(3) in vitro(3) Effective vaccines(3)